Nitinotes Surgical

📍 Caesarea, Israel🗓 Founded 2014👥 32 employees💰 Last funded Feb 2025
Nitinotes is a privately-held medical device company based in Caesarea, Israel that focuses on providing a safer and simpler suturing solution for endoscopic gastroplasty. Its flagship product, the EndoZip™, is an endoscopic robotic suturing system that has been backed by clinical success and prominent KOLs. By simplifying and speeding up the suturing process, EndoZip™ makes endoscopic gastroplasty a widely available, easy-to-perform procedure that offers an effective and minimally-invasive solution for more than 700 million patients with obesity class I & II for whom traditional bariatric surgery is not an option.
4
Total investors
0
Early stage
2
Mid stage
1
Late stage
2014
Founded
Investor geography2 countries
Israel
2
Switzerland
2
Investor activity2017–2025 · investors recorded per year
20171201812024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Nitinotes Surgical?
Nitinotes Surgical has 4 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Nitinotes Surgical last raise funding?
The most recent investment in Nitinotes Surgical recorded on gritt.io was in February 2025.
When was Nitinotes Surgical founded?
Nitinotes Surgical was founded in 2014.
What industry is Nitinotes Surgical in?
Nitinotes Surgical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Nitinotes Surgical based?
Nitinotes Surgical is headquartered in Caesarea, Israel.